These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8093761)

  • 1. Immunotherapy for HIV infection.
    Lancet; 1993 Jan; 341(8838):171. PubMed ID: 8093761
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive immunotherapy.
    Res Initiat Treat Action; 1999 Jan; 5(1):19. PubMed ID: 11366227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lesson from the HIV patient: the immune response is still the bane (or promise) of gene therapy.
    Koenig S
    Nat Med; 1996 Feb; 2(2):165-7. PubMed ID: 8574959
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibility of immunotherapy against HIV infection].
    Matsushita S
    Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):638-43. PubMed ID: 11296361
    [No Abstract]   [Full Text] [Related]  

  • 5. Adoptive therapy with purified CD8 cells in HIV infection.
    Herberman RB
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):35-40. PubMed ID: 1535457
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical impact of adoptive therapy with purified CD8 cells in HIV infection.
    Klimas NG
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):40-3; discussion 43-4. PubMed ID: 1535458
    [No Abstract]   [Full Text] [Related]  

  • 7. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R; Torbett BE; Gulizia RJ; Leath S; Mosier DE; Koenig S
    J Immunol; 1994 Nov; 153(10):4826-33. PubMed ID: 7963548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and feasibility of harvesting cells for adoptive immunotherapy from patients with asymptomatic HIV infection.
    Trickett A; Dwyer J; Tedla N; Lam-Po-Tang R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):523-4. PubMed ID: 8757432
    [No Abstract]   [Full Text] [Related]  

  • 10. Mathematical modelling of immunotherapy in HIV infection.
    Dolezal J; Hraba T
    Folia Biol (Praha); 1994; 40(4):193-9. PubMed ID: 7851617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [One antibody preparation is not another: the role of passive immunotherapy in the treatment of HIV infection].
    Leverstein-van Hall MA; Goudsmit J
    Ned Tijdschr Geneeskd; 1995 Feb; 139(7):316-20. PubMed ID: 7877699
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of cytotoxic T lymphocytes specific for autologous Epstein-Barr virus in HIV-infected patients: the feasibility study of EBV-specific immunotherapy for patients with EBV-associated lymphoma.
    Hansasuta P; Incomserb P; Buranapraditkun S; Bhattarakosol P
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S146-51. PubMed ID: 16083179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of HIV co-receptor expression: implications for pathogenesis and treatment.
    Rowland-Jones S; Tan R
    Trends Microbiol; 1997 Aug; 5(8):300-2; discussion 302-3. PubMed ID: 9263404
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis.
    Hoffmann C; Stellbrink HJ; Dielschneider T; Degen O; Stoehr A; Knechten H; Wolf E; van Lunzen J
    Br J Haematol; 2007 Feb; 136(4):641-8. PubMed ID: 17223918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
    Lucas KG; Sun Q
    Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
    Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
    AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive cellular immunotherapy for viral diseases.
    Fujita Y; Rooney CM; Heslop HE
    Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononuclear cell adoptive immunotherapy.
    Lee JH; Klein HG
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1203-21. PubMed ID: 7860445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of systemic cytomegalovirus infection in severe combined immunodeficiency using allogeneic bone marrow transplantation followed by adoptive immunotherapy.
    Koura U; Sakaki-Nakatsubo H; Otsubo K; Nomura K; Oshima K; Ohara O; Wada T; Yachie A; Imai K; Morio T; Miyawaki T; Kanegane H
    J Investig Allergol Clin Immunol; 2014; 24(3):200-2. PubMed ID: 25011361
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.
    Masiero S; Del Vecchio C; Gavioli R; Mattiuzzo G; Cusi MG; Micheli L; Gennari F; Siccardi A; Marasco WA; Palù G; Parolin C
    Gene Ther; 2005 Feb; 12(4):299-310. PubMed ID: 15496956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.